ELSAcan

MEDICINAL CANNABIS

From February 2019, INFARMED I.P, the Portuguese Medicines Regulatory Agency, approved the use of Cannabis for seven therapeutic and medicinal purposes.

Following these legal and policy changes in the use of Cannabis in Portugal and the rest of Europe, ELS Solutions has been active in this market in a variety of ways, including:

In addition to the active participation in these issues in Portugal, ELS Solutions has also participated in ANVISA's discussion of Public Consultations published in Brazil, contributing to Portugal's regulatory model for initiating the regulation of Cannabis for medicinal purposes in Brazil.

ELS Solutions can offer your company seed-to-sale guidance by becoming an extension of your team, through all the necessary steps on launching your product, from:

ELS Solutions is the partner of choice into all steps including but not limited to: